Loading clinical trials...
Loading clinical trials...
The primary objectives of this study are to assess the efficacy of levetiracetam XR in increasing the percentage of subjects with no heavy drinking days and in reducing the weekly percentage of heavy ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NCT06676059 · Alcoholism, Substance-Related Disorders
NCT06939088 · Alcohol Use Disorder, Alcohol Abuse/Dependence, and more
NCT06493773 · Liver Diseases, Alcoholic, Alcohol Use Disorder, and more
NCT04773691 · Alcoholism, rTMS Stimulation
NCT06916754 · Alcohol-Related Disorders, Alcoholism, and more
Johns Hopkins School of Medicine
Baltimore, Maryland
Boston University School of Medicine
Boston, Massachusetts
Dartmouth Medical School
Lebanon, New Hampshire
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions